A meta-analysis showed that ω-3 PUFAs could improve the nutritional status of patients after gastrectomy of gastric cancer and downregulate the levels of inflammatory indicators, such as C-reactive protein (CRP) and interleukin 6 (IL-6) [7]. This evidence concerns the gene IL6 and gastric cancer.